| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 06/21/2006 | CN1791591A Bioreductively-activated prodrugs |
| 06/20/2006 | CA2235017C 4a,5a,8a,8b-tetrahydro-6h-pyrrolo[3,4':4,5]furo(3,2-b)pyridine-6,8[7h]-dione derivatives for use in controlling endoparasites and a method of producing said derivatives |
| 06/15/2006 | US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 06/15/2006 | US20060128732 enzyme inhibitor of phosphotidylinositol-3-kinase (PI3K); N-(7,8-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)nicotinamide; antiinflammatory agent, immunomodulators; asthma, dermatitis, rhinitis, allergic diseases, chronic obstructive pulmonary disease, rheumatoid arthritis, Graves' disease |
| 06/15/2006 | US20060128728 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors |
| 06/15/2006 | US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 06/15/2006 | US20060128638 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
| 06/15/2006 | US20060128612 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/15/2006 | CA2590711A1 Antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 06/14/2006 | EP1668017A1 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
| 06/14/2006 | EP1668015A2 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compounds and uses thereof |
| 06/14/2006 | EP1668012A1 Method for preparing cucurbiturils |
| 06/13/2006 | US7061791 High density molecular memory device |
| 06/13/2006 | US7060843 Electroluminescent devices comprising diketopyrrolopyrroles |
| 06/13/2006 | CA2131103C Pyrido[1,2,3-d,e][1,3,4]benzoxadiazine derivatives |
| 06/08/2006 | WO2006131552A1 Alpha-carbolines as cdk-1 inhibitors |
| 06/08/2006 | WO2006044504A8 Cgrp receptor antagonists |
| 06/08/2006 | CA2610347A1 Alpha-carbolines as cdk-1 inhibitors |
| 06/07/2006 | EP1664059A1 Thienopyrroles as antiviral agents |
| 06/07/2006 | EP1663219A2 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
| 06/07/2006 | EP1663107A2 Rifamycin analogs and uses thereof |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | CN1784400A Quinuclidine derivatives binding to mucarinic M3 receptors |
| 06/07/2006 | CN1781938A Method for preparing echinocandin derivatives |
| 06/07/2006 | CN1258533C Antihistaminic spiro compounds |
| 06/06/2006 | US7057046 Lactam glycogen phosphorylase inhibitors and method of use |
| 06/06/2006 | US7057039 Method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I |
| 06/01/2006 | WO2006011811A3 Radicals and their use as paramagnetic agents in a dynamic nuclear polarisation process |
| 06/01/2006 | US20060116512 3-Oxo-3,4-dihydro-2H-benzo[1,4]thiazine-6-sulfonic acid {3-[(R)-5-(6-methoxy-quinolin-4-yl)-2-oxo-oxazolidin-3-yl]-propyl}-amide; to treat bacterial infections specially drug resistant |
| 06/01/2006 | US20060116394 Fab I inhibitors |
| 05/31/2006 | EP1660502A2 MODULATION OF ß-CATENIN/TCF ACTIVATED TRANSCRIPTION |
| 05/31/2006 | EP1660475A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/30/2006 | US7053093 Nitrogen compounds such as 1-((3- Phenylimidazo(5,1-a)-isoquinolin-6-yl)carbonyl)piperidine, that bind preferentially to gamma-aminobutyric acid (GABAA) receptors; prophylaxis of nervous system disorders |
| 05/30/2006 | US7053089 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA) |
| 05/24/2006 | EP1658291A2 Substituted 8-heteroaryl xanthines |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/23/2006 | US7049311 Pyrrolbenzodiazepines |
| 05/23/2006 | US7049310 Therapy for bacteria infections |
| 05/18/2006 | WO2006052568A2 Tgf-beta inhibitors |
| 05/18/2006 | WO2006052378A1 Constrained compounds as cgrp-receptor antagonists |
| 05/18/2006 | WO2006051413A1 Azabenoxazoles for the treatment of cns disorders |
| 05/18/2006 | WO2006051410A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | WO2006051407A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | WO2006051394A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | US20060106020 Tetracyclic inhibitors of Janus kinases |
| 05/18/2006 | CA2587826A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | CA2587461A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | CA2586370A1 Constrained compounds as cgrp-receptor antagonists |
| 05/17/2006 | EP1558252A4 Substituted furo 2,3-b| pyridine derivatives |
| 05/17/2006 | EP1423391B1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 05/17/2006 | CN1256337C Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza cyclopenta [A] naphthalene |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | CN1771298A Fluorescent diketopyrrolopyrroles |
| 05/10/2006 | CN1255405C Substituted pyrazoles |
| 05/09/2006 | USRE39094 absorb light further in the red, optimizing tissue penetration and are retained in the skin for short time periods relative to other drugs used in photodynamic cancer therapy |
| 05/09/2006 | US7042755 High density non-volatile memory device |
| 05/09/2006 | US7041819 Separation technology, environmental remediation, and biomedical applications such as dialysis and drug delivery |
| 05/09/2006 | US7041763 Photochromic polymers and methods of synthesizing same |
| 05/09/2006 | US7041695 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 05/04/2006 | WO2006010040A3 Antibacterial agents |
| 05/04/2006 | WO2005118777A3 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 05/03/2006 | EP1543011B1 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
| 05/03/2006 | EP1474471B1 Selective oxidation of sodium sulfide in kraft cooking liquors |
| 05/03/2006 | CN1765899A Diazabicyclic central nervous system active agents |
| 05/02/2006 | US7038052 Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline |
| 05/02/2006 | US7038051 Imidazonaphthyridines |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 04/27/2006 | WO2006044869A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| 04/27/2006 | WO2006044504A1 Cgrp receptor antagonists |
| 04/27/2006 | WO2006043145A1 Inhibitors of hepatitis c virus protease, and compositions and treatments using the same |
| 04/27/2006 | US20060089362 N-(2- piperazinophenyl) methyl 3-(3-chlorophenyl)-pyrazolo-[1,5-a]-pyrimidine-6-amide; treats circulatory diseases such as diseases due to inflammation, circulatory disorders, enhanced proliferation activities, and the like, i.e., hypertension, diabetes, diabetic complications, arteriosclerosis |
| 04/27/2006 | US20060089354 ligands for receptor localization studies; for inhibiting binding of vanilloid ligand to a capsaicin receptor; Phosphoric acid dibenzyl ester 4-(4-tert-butyl-phenylamino)-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-2-ylmethyl ester; to treat neuropathic pain, itch, urinary incontinence, cough, obesity |
| 04/27/2006 | CA2584368A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| 04/27/2006 | CA2583536A1 Cgrp receptor antagonists |
| 04/27/2006 | CA2583152A1 Inhibitors of hepatitis c virus protease, and compositions and treatments using the same |
| 04/26/2006 | EP1650203A1 Process of preparation of benzimidazol-2-yl quinolinone derivatives |
| 04/26/2006 | EP1648904A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 04/26/2006 | EP1648901A1 Substituted furochromene compounds of antiinflammatory action |
| 04/26/2006 | EP1648883A2 Lanthanide complexes preparation and uses thereof |
| 04/26/2006 | EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 04/26/2006 | EP1309592B1 Substituted pyrazoles |
| 04/26/2006 | EP1210348B9 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 04/26/2006 | CN1763047A Vinorelbine preparation method |
| 04/20/2006 | WO2005111039A3 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| 04/20/2006 | WO2005023255A3 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | CN1761664A Immunomodulating heterocyclic compounds |
| 04/19/2006 | CN1252074C Compound, its preparation method and its application |
| 04/18/2006 | US7029606 Hyperpolarizable organic chromophores |
| 04/18/2006 | CA2273374C Trioxane dimer compounds having antiproliferative and antitumor activities |
| 04/18/2006 | CA2241852C Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 04/13/2006 | WO2006037875A1 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors |
| 04/13/2006 | WO2006037869A2 Fluorophosphonocinnamic compounds, synthesis and uses for treating disorders caused by oxidative stress |
| 04/13/2006 | WO2006008251A3 Process for the photoactivation and use of a catalyst by an inverted two-stage procedure |
| 04/13/2006 | US20060079549 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength |
| 04/13/2006 | US20060079530 Farnesyl transferase inhibitors |
| 04/13/2006 | CA2580831A1 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors |
| 04/12/2006 | EP1645552A1 Double-spiro organic compounds and electroluminescent devices |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |